Solventum (SOLV) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Solventum: Improvements Come Slow
Solventum shares have traded sideways post-spin, as investors digest separation impacts, stranded costs, and recent capital allocation moves. Despite a $4.1B divestment and targeted $500M cost savings, 2025 results showed minimal free cash flow and only modest earnings growth. 2026 guidance calls for 2-3% organic sales growth and adjusted EPS of $6.50, but free cash flow remains weak at ~$200M.
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
SOLV's Q4 earnings and revenues beat estimates, driven by organic growth across MedSurg, Dental and HIS, despite margins declined.
Solventum Corporation (SOLV) Q4 2025 Earnings Call Transcript
Solventum Corporation (SOLV) Q4 2025 Earnings Call Transcript
Solventum (SOLV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Solventum (SOLV) Surpasses Q4 Earnings and Revenue Estimates
Solventum (SOLV) came out with quarterly earnings of $1.57 per share, beating the Zacks Consensus Estimate of $1.5 per share. This compares to earnings of $1.41 per share a year ago.
Solventum beats quarterly estimates on strong demand for surgical products
Medical device maker Solventum on Thursday beat Wall Street estimates for the fourth quarter, helped by strong demand for its wound care and sterilization products.
Curious about Solventum (SOLV) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Solventum (SOLV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Solventum to Post Q4 Earnings: What's in Store for the Stock?
SOLV readies Q4 results amid solid momentum, tariff headwinds, and M&A focus as investors watch margins and growth trends closely.
SOLV Energy: Powering Higher As A Public Business
SOLV Energy surged 20% post-IPO, reflecting optimism about its power infrastructure services and strong 2025 growth projections. Despite a robust backlog and margin gains, the recent revenue declines and lumpy results raise concerns about valuation and sustainability. At $30/share, the stock trades at ~25x earnings and 18x adjusted EBITDA, compared to larger, diversified peers.
SOLV Energy fetches $6 billion valuation in strong Nasdaq debut
SOLV Energy's shares rose 20% in its New York debut on Wednesday, giving the solar and battery storage firm a valuation of $5.98 billion, underscoring a strong rebound in IPO activity in 2026.
SOLV Energy targets $5 billion valuation in US IPO
Solar and battery storage firm SOLV Energy said on Friday it is targeting a valuation of up to $4.99 billion in its initial public offering in the United States.
